Premium
CHIDAMIDE WITH PEL REGIMEN (PREDNISONE, ETOPOSIDE, LENALIDOMIDE) FOR ELDER OR FRAIL PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE BCELL LYMPHOMA
Author(s) -
Wang Y.,
Xue H.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.33_2881
Subject(s) - medicine , lenalidomide , regimen , diffuse large b cell lymphoma , prednisone , etoposide , rituximab , surgery , autologous stem cell transplantation , chemotherapy regimen , oncology , transplantation , lymphoma , chemotherapy , multiple myeloma